Clinical Trial Update: Dipyridamole Assessment for Flare Reduction in Systemic Lupus Erythematosus (SLE) [NA]

View source ↗

Summary

A terminated clinical trial assessing dipyridamole for flare reduction in systemic lupus erythematosus; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Dipyridamole (Dipyridamole)

Snippet

Sponsor: Oklahoma Medical Research Foundation | Conditions: Systemic Lupus Erythematosus | NA | Status: TERMINATED | Results posted: 2020-11-25